Visual hallucinations at the onset of tolterodine treatment in a patient with a high-level spinal cord injury

BJU International

Volumn 84, Issue 9, 1999, Pages 1109-

  Malavaud, B ^a   Bagheri, H ^b   Senard, J M ^a   Sarramon, J P ^a  

^a CHU PURPAN   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TOLTERODINE; URINARY TRACT SPASMOLYTIC AGENT;

ADULT; ARTICLE; BLADDER CAPACITY; BLADDER CATHETERIZATION; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HUMAN; HYSTERECTOMY; PRIORITY JOURNAL; SPINAL CORD INJURY; VISUAL HALLUCINATION;

BENZHYDRYL COMPOUNDS; CRESOLS; FEMALE; HALLUCINATIONS; HUMANS; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PHENYLPROPANOLAMINE; REFLEX, ABNORMAL; SPINAL CORD INJURIES;

EID: 0032759631     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1999.00373.x     Document Type: Article

References (4)

1. 1 Perry EK, Perry RH. Acetylcholine and hallucinations: disease related compared to drug-induced alterations in human consciousness. Brain Cogn 1995; 28: 240-58
2. 2 Abrams P, Freeman R, Anderstrom C, Mattiasson A. Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder. Br J Urol 1998; 81: 801-10
3. 3 Baker JH, Silver JR. Atropine toxicity in acute cervical spinal injury, Paraplegia 1984; 22: 379-82
4. 4 Karlsson AK, Friberg P, Lonroth P Sullivan L, Elam M. Regional sympathetic function in high spinal cord injury during mental stress and autonomic dysreflexia, Brain 1998; 121: 1711-9